Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of “Hold” by Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been assigned a consensus rating of “Hold” from the nineteen analysts that are currently covering the company, Marketbeat reports. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month target price among brokers that have covered the stock in the last year is $9.71.

Several research firms have commented on TDOC. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday, May 1st. The Goldman Sachs Group lowered their price target on shares of Teladoc Health from $13.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, May 1st. Bank of America cut their price objective on shares of Teladoc Health from $9.50 to $8.00 and set a “neutral” rating for the company in a report on Friday, April 11th. Oppenheimer lowered their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Finally, Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th.

Teladoc Health Stock Up 3.7%

NYSE:TDOC opened at $7.62 on Wednesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company’s fifty day moving average price is $7.68 and its 200-day moving average price is $9.40. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The firm has a market capitalization of $1.34 billion, a P/E ratio of -1.32 and a beta of 1.82.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, equities research analysts anticipate that Teladoc Health will post -1.16 EPS for the current year.

Insider Transactions at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.58% of the company’s stock.

Institutional Trading of Teladoc Health

Several large investors have recently bought and sold shares of TDOC. Vanguard Group Inc. lifted its stake in Teladoc Health by 7.0% in the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock worth $157,229,000 after purchasing an additional 1,289,183 shares in the last quarter. Point72 Asset Management L.P. increased its holdings in shares of Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after purchasing an additional 2,813,568 shares during the last quarter. Renaissance Technologies LLC lifted its position in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock worth $51,582,000 after buying an additional 763,265 shares in the last quarter. Geode Capital Management LLC boosted its stake in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after buying an additional 22,664 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. boosted its stake in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after buying an additional 2,331,000 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.